The event will feature a dynamic program of keynote and plenary presentations, interactive symposia, and discussions, providing in-depth insights into the latest breakthroughs in the field. Attendees will gain valuable knowledge about the potential of bioartificial organs to improve patient care, as well as their ethical and societal implications. By offering a platform for diverse perspectives, ESAO 2025 will inspire thought-provoking conversations that push the boundaries of what is possible in medicine.
Overview
Plenary lectures
Stephen R. Ash, MD, FACP
CEO of HemoCleanse Technologies LLC
Shuvo Roy, PhD
Department of Bioengineering & Therapeutic Sciences
UC San Francisco (UCSF). Faculty Director, UCSF-UC Berkeley Master of Translational Medicine (MTM) Program
Prof. Dr. Andries van der Meer
Professor of Microphysiological Systems, Department of Bioengineering Technologies, Organ-on-Chip Centre Twente, University of Twente
Cristiano Amarelli, MD
Staff Surgeon at Monaldi, Azienda Ospedaliera dei Colli, Naples, Italy
